Artivion | CRY - 债务



金融业
股票价格
USD
资产
USD 1.07B
现金及等价物
USD 77.32M
销售成本
USD 42.85M
流动资产
USD 371.38M
流动负债
USD 106.93M
债务
USD 317.78M
EBIT
USD 4.79M
EBITDA
USD 22.72M
员工
1.5K
EPS每股收益
USD -0.02
股本和储备
USD 445.59M
销售毛利
USD 73.14M
债务利息支出
USD 5.53M
利息收入
USD -0.05
贷款资金
USD 363.42M
市值
USD 1.01B
净收入
USD 2.42M
营业费用
USD 111.2M
营业利润
USD 4.79M
普通股股本
USD 47.84M
PE价格收益
212.38
税前利润
USD 11.4M
销售收入
USD 115.99M
销售和管理费用
USD 55.75M
股票
USD 103.36M
贸易债权人
USD 20.87M
应收帐款人
USD 103.68M


债务 更改 日
Abbott USD 34.05B 20.19B 2026-03
Accuray USD 170.24M 4.52M 2024-09
AngioDynamics USD 6.3M 6.3M 2025-02
Artivion USD 317.78M 619K 2024-12
AtriCure USD 71.78M 1.6M 2026-03
Baxter International USD 9.69B 93M 2026-03
Becton, Dickinson and Co. USD 17.28B 2.26B 2026-03
Boston Scientific USD 11.03B 407M 2026-03
Edwards Lifesciences USD 600M 105.4M 2026-03
Inogen USD 0 0 2022-06
Integra LifeSciences USD 2.04B 6.27M 2026-03
J&J USD 54.99B 7.05B 2026-03
Mesa Laboratories USD 204.98M 7.27M 2024-09
Orthofix International USD 137.23M 338K 2024-09
Pfizer USD 63.19B 536M 2026-06
ResMed USD 843.17M 4.55M 2026-03
Stryker USD 14.19B 32M 2026-06
Tandem Diabetes Care USD 602.58M 132.16M 2026-06
Teleflex USD 2.69B 39.95M 2026-03
Terumo JPY 379.8B 219.92B 2026-03
Trinity Biotech USD 137.98M 37.22M 2025-12